# Drug Design Development and Therapy

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/drug-design-development-and-therapy/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 2,836 |
| Citations | 143,482 |
| h-index | 129 |
| Homepage | http://www.dovepress.com/drug-design-development-and-therapy-journal |
| Open Access | true |
| ISSN-L | 1177-8881 |
| ISSNs | 1177-8881 |
| OpenAlex ID | https://openalex.org/S2496126384 |
| Publisher | Dove Medical Press |
| Works | 5,796 |

## Journal papers

Showing 12 of 34.

- [Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date](https://scholariq.org/papers/naltrexone-sustained-release-bupropion-sustained-release-for-the-management-of/)
- [Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues](https://scholariq.org/papers/phase-iii-study-of-pasireotide-long-acting-release-in-patients-with-metastatic/)
- [The Risks of miRNA Therapeutics: In a Drug Target Perspective](https://scholariq.org/papers/the-risks-of-mirna-therapeutics-in-a-drug-target-perspective/)
- [Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria](https://scholariq.org/papers/synergistic-effects-of-antimicrobial-peptide-dp7-combined-with-antibiotics/)
- [Tocilizumab in the treatment of rheumatoid arthritis and beyond](https://scholariq.org/papers/tocilizumab-in-the-treatment-of-rheumatoid-arthritis-and-beyond/)
- [A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer](https://scholariq.org/papers/a-current-review-of-folate-receptor-alpha-as-a-and-amp-nbsp-potential-tumor/)
- [Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration](https://scholariq.org/papers/vascular-endothelial-growth-factor-antagonists-promising-players-in-the/)
- [Remimazolam for the Prevention of Emergence Delirium in Children Following Tonsillectomy and Adenoidectomy Under Sevoflurane Anesthesia: A Randomized Controlled Study](https://scholariq.org/papers/remimazolam-for-the-prevention-of-emergence-delirium-in-children-following/)
- [<p>Exosomes Derived From Bone Marrow Mesenchymal Stem Cells Inhibit Complement Activation In Rats With Spinal Cord Injury</p>](https://scholariq.org/papers/and-lt-p-and-gt-exosomes-derived-from-bone-marrow-mesenchymal-stem-cells-inhibit/)
- [Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies](https://scholariq.org/papers/faricimab-transforming-the-future-of-macular-diseases-treatment-a-comprehensive/)
- [<p>The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease</p>](https://scholariq.org/papers/and-lt-p-and-gt-the-protective-effect-and-mechanism-of-the-fxr-agonist/)
- [Decreased expression of the APOA1–APOC3–APOA4 gene cluster is associated with risk of Alzheimer’s disease](https://scholariq.org/papers/decreased-expression-of-the-apoa1-and-amp-ndash-apoc3-and-amp-ndash-apoa4-gene/)

## Journal top topics

Showing 8 of 25.

- [Anesthesia and Sedative Agents](https://scholariq.org/topics/anesthesia-and-sedative-agents/)
- [Anesthesia and Pain Management](https://scholariq.org/topics/anesthesia-and-pain-management/)
- [Advanced Drug Delivery Systems](https://scholariq.org/topics/advanced-drug-delivery-systems/)
- [Nausea and vomiting management](https://scholariq.org/topics/nausea-and-vomiting-management/)
- [Drug Solubulity and Delivery Systems](https://scholariq.org/topics/drug-solubulity-and-delivery-systems/)
- [Intensive Care Unit Cognitive Disorders](https://scholariq.org/topics/intensive-care-unit-cognitive-disorders/)
- [Traditional Chinese Medicine Analysis](https://scholariq.org/topics/traditional-chinese-medicine-analysis/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.